Literature DB >> 23938211

Point-counterpoint: Are we overtreating patients with mild ulcerative colitis?

Akbar K Waljee1, Ryan W Stidham2, Peter D R Higgins2, Sandeep Vijan3, Sameer D Saini4.   

Abstract

Entities:  

Keywords:  5-ASA; Inflammatory Bowel Disease; Mesalamine; Ulcerative colitis

Mesh：

Substances：

Year:  2013        PMID： 23938211      PMCID： PMC6907159          DOI： 10.1016/j.crohns.2013.07.003

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  41 in total

1.  Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango).

Authors:  C Charles; A Gafni; T Whelan
Journal:  Soc Sci Med       Date:  1997-03       Impact factor: 4.634

2.  Perceived and actual quality of life with ulcerative colitis: a comparison of medically and surgically treated patients.

Authors:  Akbar K Waljee; Peter D R Higgins; Jennifer F Waljee; Shannan R Tujios; Aditi Saxena; Lindsay K Brown; Meghana N Chaudhary; Arden M Morris
Journal:  Am J Gastroenterol       Date:  2011-03-01       Impact factor: 10.864

Review 3.  5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review.

Authors:  Javier P Gisbert; Yago González-Lama; José Maté
Journal:  Inflamm Bowel Dis       Date:  2007-05       Impact factor: 5.325

4.  Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies.

Authors:  Fernando S Velayos; Jonathan P Terdiman; Judith M Walsh
Journal:  Am J Gastroenterol       Date:  2005-06       Impact factor: 10.864

5.  Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis.

Authors:  S V Kane; R D Cohen; J E Aikens; S B Hanauer
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

6.  Increasing patient adherence to gastroenterology treatment and prevention regimens.

Authors:  R L Levy; A D Feld
Journal:  Am J Gastroenterol       Date:  1999-07       Impact factor: 10.864

7.  Risk factors for neoplasia in inflammatory bowel disease patients with pancolitis.

Authors:  Vivianne Bergeron; Ariane Vienne; Harry Sokol; Philippe Seksik; Isabelle Nion-Larmurier; Agnès Ruskone-Fourmestraux; Magali Svrcek; Laurent Beaugerie; Jacques Cosnes
Journal:  Am J Gastroenterol       Date:  2010-06-15       Impact factor: 10.864

8.  5-aminosalicylic acid is not protective against colorectal cancer in inflammatory bowel disease: a meta-analysis of non-referral populations.

Authors:  Geoffrey C Nguyen; Aliya Gulamhusein; Charles N Bernstein
Journal:  Am J Gastroenterol       Date:  2012-07-03       Impact factor: 10.864

9.  Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

Authors:  Matthew Rutter; Brian Saunders; Kay Wilkinson; Steve Rumbles; Gillian Schofield; Michael Kamm; Christopher Williams; Ashley Price; Ian Talbot; Alastair Forbes
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

10.  5-aminosalicylic acids and the risk of renal disease: a large British epidemiologic study.

Authors:  Tjeerd P Van Staa; Simon Travis; Hubert G M Leufkens; Richard F Logan
Journal:  Gastroenterology       Date:  2004-06       Impact factor: 22.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.